中文 
别名:EPI; TFI; LACI; TFPI1应用:WB
反应种属:Human
规格：50μl/100μl
| Description |
|---|
| Inhibits factor X (X(a)) directly and, in a Xa-dependent way, inhibits VIIa/tissue factor activity, presumably by forming a quaternary Xa/LACI/VIIa/TF complex. It possesses an antithrombotic action and also the ability to associate with lipoproteins in plasma. |
| Specification | |
|---|---|
| Aliases | EPI; TFI; LACI; TFPI1 |
| Entrez GeneID | 7035 |
| Swissprot | P10646 |
| WB Predicted band size | Calculated MW: 35 kDa; Observed MW: 40-55 kDa |
| Host/Isotype | Rabbit IgG |
| Storage | Store at 4°C short term. Aliquot and store at -20°C long term. Avoid freeze/thaw cycles. |
| Species Reactivity | Human |
| Immunogen | A synthetic peptide of human TFPI |
| Formulation | 50mM Tris-Glycine(pH 7.4), 0.15M NaCl, 40% Glycerol, 0.01% Sodium azide and 0.05% BSA |
| Application | |
|---|---|
| WB | 1/500-1/1000 |
 |
Western blot analysis of TFPI in A549, MCF-7 lysates using TFPI antibody. |
本公司的所有产品仅用于科学研究或者工业应用等非医疗目的，不可用于人类或动物的临床诊断或治疗，非药用，非食用。
暂无评论
本公司的所有产品仅用于科学研究或者工业应用等非医疗目的，不可用于人类或动物的临床诊断或治疗，非药用，非食用。
发表回复